Inactivated COVID-19 Vaccine Response in SLE, Rheumatoid Arthritis
Researchers investigated the seroreactivity of COVID-19 vaccination and adverse events among patients with systemic lupus erythematosus and rheumatoid arthritis.
All articles by Emily Pond
Severe COVID-19 Outcomes Rare Among Children and Young People With Rheumatic Diseases
Researchers sought to determine the outcomes among pediatric patients with rheumatic disease and COVID-19.
Hepatitis B Risk Not Substantially Elevated With Celiac Disease
Researchers sought to determine whether patients with celiac disease are at increased risk for HBV infection despite having received HBV vaccination.
What Is the Estimated Global Prevalence of Hepatitis C by 2030?
Researchers investigated HCV’s burden in 2020 and projected global burden for 2030.
Decubitus Ulcer Risk in ICU Patients With COVID-19
Independent risk factors for pressure ulcers in ICU patients admitted with COVID-19 are identified from patient data.
Fecal Microbiota Transplantation in Children With Underlying Gastric Conditions
Investigators assessed the impact of underlying comorbidities on the efficacy of fecal microbiota transplantation in children with recurrent Clostridioides difficile infection.
Antibody Response After COVID-19 Vaccine Series Observed in Patients With Rheumatic Disease
Study authors described antibody responses among patients with rheumatic and musculoskeletal diseases receiving immunosuppressant therapy 6 months after completing the COVID-19 vaccine series.
Mother’s Own Milk Associated With Postnatal Growth in Extremely Preterm Infants
Investigators assessed the effects of intake of mother’s own milk vs pasteurized donor milk on postnatal outcomes in extremely preterm infants.
Novel Microbiome Therapy Reduces Risk for Recurrent C Difficile Infection
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
Decline in Self-Harm, Overdose Rates in Adolescents During COVID-19 Pandemic
A study assessed the risk for self-harm, overdose, and all-cause mortality in adolescents and young adults during the COVID-19 pandemic.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...